Chapter 5: Key factors that influence biosimilar in vitro and in vivo nonclinical testing strategies

Doi: 10.4155/FSEB2013.14.324 Author Kelly S Colletti Senior Research Scientist Laboratory Sciences, Charles River 6995 Longley Lane, Reno NV 89511, USA Tel: +1 775 682 2145 e-mail: [email protected] About the author Kelly Colletti obtained her PhD in Cellular and Molecular Biology at the University of Nevada, Reno in 2005.  She is a trained herpes virologist that studied the molecular mechanisms of Cytomegalovirus and Karposi’s Sarcoma Associated Herpes Virus DNA replication.  While pursuing her doctoral degree, she learned a diverse set of skills including protein expression and purification, antibody generation, enzymatic assay development, cell culture, molecular biology and protein chemistry.  She also...